Friday, 30 September 2022

Saumen Chakraborty joins Premas Biotech's Board of Directors

09 May 2022 | News

Chakraborty has over 37 years of experience in both strategic and operational aspects of management

Image credit: Linkedin

Image credit: Linkedin

Premas Biotech has appointed Saumen Chakraborty to the Premas Biotech Board of Directors.

 

Chakraborty is the Managing Director of Samarjita Management Consultancy. He retired as the President and Chief Financial Officer of Dr Reddy’s in 2020 and served as an advisor to them for the next year. He has over 37 years of experience in both strategic and operational aspects of management and has played a significant role in the evolution of Dr Reddy's as a global pharmaceutical company in India. He served at the CXO level in multiple areas ranging from global finance, legal & compliance, digital & process excellence, global HR, quality, and corporate & global generics operations at Dr Reddy's.

 

As the Chief Financial Officer, Saumen has been awarded the 'India's Best CFO' by IMA, 2016 & 'India's Best CFO with Exemplary All Round Performance' in the '5th Annual Business Today – YES Bank BEST CFO Awards' 2014. Other key portfolios and initiatives Chakraborty has handled in his current and previous roles at CMC, C-DOT, Eicher, Tecumseh and Dr Reddy’s include manufacturing, sourcing, customer service, quality, consulting, HR and IT.

 

Chakraborty is a postgraduate in management from IIM, Ahmedabad and an executive fellow in management from ISB, Hyderabad. His doctoral dissertation at ISB was ‘How to do dynamic resource allocation in the generic pharmaceutical industry?’. 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account